IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boxer Capital Management, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 28 holdings | $332.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2026-02-17) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$46.6M1,317,97714.0%
Nuvalent Inc(NUVL)COM670703107$31.9M450,0009.6%
Merus N VCOMN5749R100$29.5M700,0008.9%
Avidity Biosciences Inc(RNA)COM05370A108$25.5M865,0007.7%
Anaptysbio Inc(ANAB)COM032724106$24.2M1,300,0007.3%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$20.1M600,0006.1%
Replimune Group Inc(REPL)COM76029N106$17.5M1,796,3415.3%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$15.6M713,0004.7%
Chimerix Inc(CMRXEUR)COM16934W106$15.4M1,810,0004.6%
Tango Therapeutics Inc(TNGX)COM87583X109$14.2M10,380,9994.3%
Enliven Therapeutics Inc(ELVN)COM29337E102$13.2M671,3584.0%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$9.7M1,732,5712.9%
DAY One Biopharmaceuticals I(DAWN)COM23954D109$9.4M1,189,9432.8%
Kymera Therapeutics Inc(KYMR)COM501575104$8.9M325,0002.7%
Prothena Corp PLC(PRTA)SHSG72800108$8.5M690,0002.6%
Uniqure NV(QURE)SHSN90064101$8.0M750,0002.4%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$6.8M200,0002.0%
Nurix Therapeutics Inc(NRIX)COM67080M103$6.7M563,0672.0%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$6.2M1,750,0001.9%
Solid Biosciences Inc(SLDB)COM NEW83422E204$4.6M1,240,7001.4%
Denali Therapeutics Inc(DNLI)COM24823R105$3.4M250,0001.0%
Kodiak Sciences Inc(KOD)COM50015M109$2.9M1,035,0000.9%
Prelude Therapeutics Inc(PRLD)COM74065P101$1.6M2,108,0140.5%
Instil BIO Inc(TIL)COM NEW45783C200$1.4M80,1250.4%
Boundless BIO Inc(BOLD)COM10170A100$377.5K250,0000.1%
Climb BIO Inc(CLYM)COM28658R106$176.9K145,0000.1%
Nuvation BIO Inc(NUVB/WS)*W EXP 02/10/20267080N119$85.3K266,6660.0%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$2.0K66,6660.0%